SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001286868-20-000002
Filing Date
2020-10-13
Accepted
2020-10-13 14:17:16
Documents
1
Period of Report
2020-08-12

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 2123
  Complete submission text file 0001286868-20-000002.txt   3590
Mailing Address C/O ADVANCED MEDICAL ISOTOPE CORP. 1021 N. KELLOGG STREET KENNEWICK WA 99336
Business Address
KATZAROFF JAMES C (Reporting) CIK: 0001286868 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-55072 | Film No.: 201235907

Mailing Address 2500 WILCREST DRIVE, 3RD FLOOR HOUSTON TX 77042
Business Address 2500 WILCREST DRIVE, 3RD FLOOR HOUSTON TX 77042 832-781-8521
AngioSoma, Inc. (Issuer) CIK: 0001502152 (see all company filings)

IRS No.: 273480481 | State of Incorp.: NV | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences